Group testing, where individuals are tested initially in pools, is often used to screen a large number of individuals for rare diseases. Triggered by the recent development of assays that detect multiple infections, large-scale screening programs now involve testing individuals in pools for multiple infections simultaneously. Tebbs, McMahan, and Bilder (2013, Biometrics) recently evaluated the performance of a two-stage hierarchical algorithm used to screen for chlamydia and gonorrhea as part of the Infertility Prevention Project in the United States. In this article, we generalize this work to accommodate a larger number of stages. To derive the operating characteristics of higher-stage hierarchical algorithms with more than one infection, we view the pool decoding process as a time-inhomogeneous, finite-state Markov chain. Taking this conceptualization enables us to derive closed-form expressions for the expected number of tests and classification accuracy rates in terms of transition probability matrices. When disease probabilities are small, we offer compelling evidence that higher-stage algorithms can provide significant savings when screening a population for multiple infections. We also demonstrate that if prevalence estimation is an additional goal, two-stage algorithms provide most of the benefits in terms of estimation efficiency.
